{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-095443","form_type":"8-K","ticker":"BTAI","cik":"0001720893","company_name":"BioXcel Therapeutics, Inc.","filed_at":"2021-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.369405+00:00","generated_at":"2026-06-30T02:59:49.045903+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"BioXcel Therapeutics announces resignation of Chief Development Officer Reina Benabou effective July 30, 2021","bullets":["Reina Benabou, M.D., Ph.D., Chief Development Officer, tendered resignation effective July 30, 2021.","No successor or interim appointment announced in the filing.","Benabou was a named executive officer in the company's April 2021 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-095443","json":"https://secwatch.observer/filing/0001104659-21-095443.json","markdown":"https://secwatch.observer/filing/0001104659-21-095443.md","text":"https://secwatch.observer/filing/0001104659-21-095443.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720893/000110465921095443/0001104659-21-095443-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720893/000110465921095443/tm2122742d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T02:59:49.045903+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"047fbd8114","claim":"Reina Benabou resigned as Senior Vice President and Chief Development Officer at BioXcel Therapeutics, Inc..","evidence_excerpt":"On July 19, 2021, Reina Benabou, M.D., Ph.D., Senior Vice President and Chief Development Officer of BioXcel Therapeutics, Inc. (the “Company”), and a named executive officer in the Company’s proxy statement filed April 27, 2021, tendered her resignation notice to the Company, effective July 30, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465921095443/0001104659-21-095443-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Senior Vice President and Chief Development Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}